Kontrol Technologies Corp. Q1 FY2021 Earnings Call

· Earnings call transcript and AI-powered summary

  • Revenue: $3.3M for Q1 2021, representing a 20% increase compared to Q1 2020. Q1 results were impacted by project delays due to Ontario lockdowns (~$500K in deferred revenue now expected in Q3–Q4).
  • Adjusted EBITDA: $1.1M in Q1 2021, up from $241K in Q1 2020—a 356% year-over-year increase.
  • Operating Cash Flow: $593K in Q1 2021, improving by $610K over Q1 2020 (which recorded a negative $17K).
  • BioCloud Investment: $4M invested as of Q1 2021 in R&D and pre-commercialization.
  • Balance Sheet Improvements:
    • $631K in convertible debentures converted to equity in Q1 2021.
    • $710K raised from option and warrant exercises.
    • Approximately $922K in debentures extended to mature in October 2022.
  • New Institutional Capital: Announced $8.5M private placement with U.S. institutional investors (closing expected around June 1, 2021). Funding supports supply chain optimization and BioCloud production scalability.
  • BioCloud Update:
    • Two units shipped to Health Canada for post-manufacturing lab testing; results expected July 2021.
    • Exclusive distributor agreement signed with Royal Health Group in UAE following a successful pilot.

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Good afternoon. My name is Sylvie, and I will be your conference operator today. At this time, I would like to welcome everyone to Kontrol Technologies Q1 2021 Financial Results Report. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, we will conduct question-and-answer that were forwarded to us beforehand by shareholders and analysts. The CEO of Kontrol Technologies, Paul Ghezzi; and the CFO, Claudio Del Vasto are your host for today’s conference call and will provide a management comments. Before we begin, please be reminded that certain statements and information included in the Management Discussion and Analysis and financial statements and presentations, including information related to future financial or operating performance, and other statements that express the expectations of management or estimates of future performance constitute forward-looking statements. For more information on the company’s forward-looking statements, and risk factors, please reference the Management Discussion and Analysis and our financial statement for Q1 2021. For all public information filings, please visit sedar.com. Thank you. And I would like to turn the conference over to Mr. Paul Ghezzi, CEO of Kontrol Technologies. Paul, you may begin. Paul Ghezzi: Thank you. Hi, everyone. And welcome to the Kontrol Technologies Q1 2021 financial statement call. I’m joined on the call by our CFO, Claudio Del Vasto, who will summarize our fin

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional